Literature DB >> 7298788

Quantitative assay of rifampicin and its main metabolite 25-desacetylrifampicin in human plasma by reversed-phase high-performance liquid chromatography.

B Ratti, R R Parenti, A Toselli, L F Zerilli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7298788     DOI： 10.1016/s0378-4347(00)80308-4

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.

Authors:  M C Nahata; P Fan-Havard; W J Barson; H M Bartkowski; E J Kosnik
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  A sensitive method for quantitation of rifabutin and its desacetyl metabolite in human biological fluids by high-performance liquid chromatography (HPLC).

Authors:  R C Lewis; N Z Hatfield; P K Narang
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

3.  Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.

Authors:  G L Drusano; R J Townsend; T J Walsh; A Forrest; E J Antal; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

4.  Quantification of rifampicin in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic-tandem mass spectrometric method.

Authors:  Abhishek Srivastava; David Waterhouse; Alison Ardrey; Stephen A Ward
Journal:  J Pharm Biomed Anal       Date:  2012-06-01       Impact factor: 3.935

5.  Pharmacokinetic interaction of Diabecon (D-400) with rifampicin and nifedipine.

Authors:  S K Mitra; R Sundaram; M V Venkataranganna; S Gopumadhavan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.569

6.  Fast and Simple LC-MS/MS Method for Rifampicin Quantification in Human Plasma.

Authors:  Žane Temova Rakuša; Robert Roškar; Anita Klančar Andrejc; Tina Trdan Lušin; Nataša Faganeli; Iztok Grabnar; Aleš Mrhar; Albin Kristl; Jurij Trontelj
Journal:  Int J Anal Chem       Date:  2019-02-03       Impact factor: 1.885

7.  Development and validation of liquid chromatography-mass spectrometry method for the estimation of rifampicin in plasma.

Authors:  J S Patil; Sarasija Suresh; A R Sureshbabu; M S Rajesh
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

8.  Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations.

Authors:  Christoph Thiel; Ines Smit; Vanessa Baier; Henrik Cordes; Brigida Fabry; Lars Mathias Blank; Lars Kuepfer
Journal:  NPJ Syst Biol Appl       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.